• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Genpact Limited (Amendment)

    2/10/23 9:08:41 AM ET
    $G
    Professional Services
    Consumer Discretionary
    Get the next $G alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.4 GENPACT LTD COMMON STOCK Cusip #G3922B107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #G3922B107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 17,416,781 Item 6: 0 Item 7: 18,683,945 Item 8: 0 Item 9: 18,683,945 Item 11: 10.195% Item 12: HC Cusip #G3922B107 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 18,683,945 Item 8: 0 Item 9: 18,683,945 Item 11: 10.195% Item 12: IN Item 1(a). Name of Issuer: GENPACT LTD Item 1(b). Address of Issuer's Principal Executive Offices: 22 VICTORIA STREET, CANON'S COURT HAMILTON, D0 HM122 BM Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: G3922B107 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 18,683,945 (b) Percent of Class: 10.195% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 18,683,945 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of GENPACT LTD. No one other person's interest in the COMMON STOCK of GENPACT LTD is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing orinfluencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 9, 2023 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Diversifying Solutions LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company BK Strategic Advisers LLC IA * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 9, 2023, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of GENPACT LTD at January 31, 2023. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January, 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $G alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $G

    DatePrice TargetRatingAnalyst
    2/7/2025$45.00 → $60.00Hold → Buy
    TD Cowen
    1/21/2025$44.00 → $55.00Hold → Buy
    Jefferies
    7/17/2024$43.00 → $40.00Underweight → Neutral
    JP Morgan
    1/30/2024$40.00Neutral
    Mizuho
    12/15/2023$38.00Outperform → Neutral
    Robert W. Baird
    8/22/2023$40.00Neutral → Underweight
    JP Morgan
    7/18/2023$46.00 → $42.00Buy → Neutral
    Citigroup
    12/15/2022$55.00 → $50.00Overweight → Neutral
    JP Morgan
    More analyst ratings

    $G
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Gangestad Nicholas C bought $87,940 worth of shares (2,000 units at $43.97) (SEC Form 4)

      4 - Genpact LTD (0001398659) (Issuer)

      5/14/25 4:19:22 PM ET
      $G
      Professional Services
      Consumer Discretionary

    $G
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Genpact Limited Board Declares Quarterly Cash Dividend

      NEW YORK, July 10, 2025 /PRNewswire/ -- Genpact Limited (NYSE:G), a global advanced technology services and solutions company, today announced that its board of directors has declared a cash dividend of $0.17 per common share for the third quarter of 2025. The dividend is payable on September 25, 2025 to shareholders of record as of the close of business on September 11, 2025. The declaration of any future dividends will be at the discretion of the board of directors.  About Genpact Genpact (NYSE:G) is an advanced technology services and solutions company that delivers lasting

      7/10/25 4:15:00 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact to Report Second Quarter 2025 Results

      NEW YORK, July 10, 2025 /PRNewswire/ -- Genpact (NYSE:G) will report its financial results for the second quarter ended June 30, 2025 after the close of the U.S. financial markets on Thursday, August 7, 2025. Following the release, Genpact's management team will host a conference call at 5:00 p.m. ET to discuss the company's performance. Participants are encouraged to register in advance to receive a dial-in number and unique PIN for seamless access. While early log-in is recommended, registration and access will be available throughout the call. A live webcast will be availab

      7/10/25 4:05:00 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact Recognized as One of America's Best Midsize Companies by TIME

      Climbs to #100 in the 2025 top 500 list, demonstrating Genpact's commitment to innovation, people-first culture, and client impact  NEW YORK, July 10, 2025  /PRNewswire/ -- Genpact (NYSE:G), an advanced technology services and solutions company, today announced its inclusion in the TIME America's Best Midsize Companies 2025 list. This marks Genpact's second time being recognized, an achievement that reflects the company's strength across three dimensions: revenue growth, employee satisfaction, and sustainability transparency – three critical parameters on which companies were scored.  

      7/10/25 1:00:00 PM ET
      $G
      Professional Services
      Consumer Discretionary

    $G
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Hinshaw John M was granted 2,334 shares (SEC Form 4)

      4 - Genpact LTD (0001398659) (Issuer)

      7/3/25 4:12:41 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • SEC Form 3 filed by new insider Hinshaw John M

      3 - Genpact LTD (0001398659) (Issuer)

      7/3/25 4:01:04 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • Director Gangestad Nicholas C was granted 1,988 shares, increasing direct ownership by 29% to 8,813 units (SEC Form 4)

      4 - Genpact LTD (0001398659) (Issuer)

      7/2/25 4:05:59 PM ET
      $G
      Professional Services
      Consumer Discretionary

    $G
    SEC Filings

    See more
    • Genpact Limited filed SEC Form 8-K: Leadership Update

      8-K - Genpact LTD (0001398659) (Filer)

      7/1/25 4:42:02 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact Limited filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Genpact LTD (0001398659) (Filer)

      5/28/25 4:27:07 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Genpact Limited

      10-Q - Genpact LTD (0001398659) (Filer)

      5/12/25 2:48:08 PM ET
      $G
      Professional Services
      Consumer Discretionary

    $G
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Genpact upgraded by TD Cowen with a new price target

      TD Cowen upgraded Genpact from Hold to Buy and set a new price target of $60.00 from $45.00 previously

      2/7/25 7:07:51 AM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact upgraded by Jefferies with a new price target

      Jefferies upgraded Genpact from Hold to Buy and set a new price target of $55.00 from $44.00 previously

      1/21/25 7:48:14 AM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact upgraded by JP Morgan with a new price target

      JP Morgan upgraded Genpact from Underweight to Neutral and set a new price target of $40.00 from $43.00 previously

      7/17/24 7:53:33 AM ET
      $G
      Professional Services
      Consumer Discretionary

    $G
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Genpact Limited

      SC 13G/A - Genpact LTD (0001398659) (Subject)

      11/12/24 9:55:15 AM ET
      $G
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Genpact Limited (Amendment)

      SC 13G/A - Genpact LTD (0001398659) (Subject)

      6/6/24 9:54:34 AM ET
      $G
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Genpact Limited (Amendment)

      SC 13G/A - Genpact LTD (0001398659) (Subject)

      2/9/24 9:03:03 AM ET
      $G
      Professional Services
      Consumer Discretionary

    $G
    Leadership Updates

    Live Leadership Updates

    See more
    • Genpact Appoints John M. Hinshaw to Board of Directors

      NEW YORK, July 1, 2025 /PRNewswire/ -- Genpact (NYSE:G), an advanced technology services and solutions company, today announced that John M. Hinshaw has been appointed to the Company's Board of Directors, effective July 1, 2025. "We welcome John to Genpact's Board of Directors," said Balkrishan "BK" Kalra, President and CEO, Genpact. "John's extensive expertise in managing change and evolution at some of the world's largest and most recognizable brands will be a tremendous asset as we help clients leverage AI and agentic innovations to drive their businesses forward." Most rec

      7/1/25 8:05:00 AM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact Announces Chief Strategy and Corporate Development Officer

      Strategic business development leader Jinsook Han joins Genpact to spearhead strategy and M&A NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Jinsook Han has joined the Company as Chief Strategy and Corporate Development Officer, effective immediately. She will be responsible for the company's strategy and investments, including ventures and acquisitions. Jinsook will report to President and CEO, Balkrishan "BK" Kalra. "Jinsook has that rare profile that

      11/12/24 4:05:00 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact Appoints Sanjeev Vohra as First Chief Technology & Innovation Officer

      Seasoned technologist joins Genpact to accelerate AI and advanced technology roadmaps NEW YORK, Aug. 7, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Sanjeev Vohra has been named as the Company's first Chief Technology & Innovation Officer, effective immediately. Vohra will report to President and CEO, Balkrishan "BK" Kalra. Vohra, a seasoned leader and respected innovator, brings more than 30 years of technology, consulting and industry expertise to Genpact. His appointm

      8/7/24 8:16:00 AM ET
      $G
      Professional Services
      Consumer Discretionary

    $G
    Financials

    Live finance-specific insights

    See more
    • Genpact Limited Board Declares Quarterly Cash Dividend

      NEW YORK, July 10, 2025 /PRNewswire/ -- Genpact Limited (NYSE:G), a global advanced technology services and solutions company, today announced that its board of directors has declared a cash dividend of $0.17 per common share for the third quarter of 2025. The dividend is payable on September 25, 2025 to shareholders of record as of the close of business on September 11, 2025. The declaration of any future dividends will be at the discretion of the board of directors.  About Genpact Genpact (NYSE:G) is an advanced technology services and solutions company that delivers lasting

      7/10/25 4:15:00 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact to Report Second Quarter 2025 Results

      NEW YORK, July 10, 2025 /PRNewswire/ -- Genpact (NYSE:G) will report its financial results for the second quarter ended June 30, 2025 after the close of the U.S. financial markets on Thursday, August 7, 2025. Following the release, Genpact's management team will host a conference call at 5:00 p.m. ET to discuss the company's performance. Participants are encouraged to register in advance to receive a dial-in number and unique PIN for seamless access. While early log-in is recommended, registration and access will be available throughout the call. A live webcast will be availab

      7/10/25 4:05:00 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact Limited Board Declares Quarterly Cash Dividend

      NEW YORK, June 6, 2025 /PRNewswire/ -- Genpact Limited (NYSE:G), a global advanced technology services and solutions company, today announced that its board of directors has declared a cash dividend of $0.17 per common share for the second quarter of 2025. The dividend is payable on June 30, 2025 to shareholders of record as of the close of business on June 18, 2025. The declaration of any future dividends will be at the discretion of the board of directors. About Genpact Genpact (NYSE:G) is an advanced technology services and solutions company that delivers lasting value for

      6/6/25 4:15:00 PM ET
      $G
      Professional Services
      Consumer Discretionary